| pubmed-article:3761755 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3761755 | lifeskim:mentions | umls-concept:C0013227 | lld:lifeskim |
| pubmed-article:3761755 | lifeskim:mentions | umls-concept:C0025914 | lld:lifeskim |
| pubmed-article:3761755 | lifeskim:mentions | umls-concept:C0026809 | lld:lifeskim |
| pubmed-article:3761755 | lifeskim:mentions | umls-concept:C0006104 | lld:lifeskim |
| pubmed-article:3761755 | lifeskim:mentions | umls-concept:C0019588 | lld:lifeskim |
| pubmed-article:3761755 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:3761755 | lifeskim:mentions | umls-concept:C0243127 | lld:lifeskim |
| pubmed-article:3761755 | lifeskim:mentions | umls-concept:C0443331 | lld:lifeskim |
| pubmed-article:3761755 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:3761755 | pubmed:dateCreated | 1986-11-20 | lld:pubmed |
| pubmed-article:3761755 | pubmed:abstractText | The effect of GABA-mimetics on histaminergic activity in the mouse brain was investigated. Systemic administration of muscimol (2 and 5 mg/kg), THIP (5-15 mg/kg) and aminooxyacetic acid (AOAA) (25 mg/kg) but not baclofen (2.5-15 mg/kg) inhibited the pargyline (65 mg/kg)-induced accumulation of tele-methylhistamine (t-MH). There was no regional difference in the inhibitory effect of muscimol on the t-MH accumulation by pargyline treatment. Muscimol and AOAA also inhibited decrease in the histamine (HA) level induced by alpha-fluoromethylhistidine (50 mg/kg), a specific inhibitor of histidine decarboxylase. These results suggest that these GABA-mimetics reduce the HA turnover in the mouse brain. | lld:pubmed |
| pubmed-article:3761755 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3761755 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3761755 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3761755 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3761755 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3761755 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3761755 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3761755 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3761755 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3761755 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3761755 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3761755 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3761755 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3761755 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3761755 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3761755 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:3761755 | pubmed:issn | 0021-5198 | lld:pubmed |
| pubmed-article:3761755 | pubmed:author | pubmed-author:ItohYY | lld:pubmed |
| pubmed-article:3761755 | pubmed:author | pubmed-author:SaekiKK | lld:pubmed |
| pubmed-article:3761755 | pubmed:author | pubmed-author:OishiRR | lld:pubmed |
| pubmed-article:3761755 | pubmed:author | pubmed-author:NishiboriMM | lld:pubmed |
| pubmed-article:3761755 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3761755 | pubmed:volume | 41 | lld:pubmed |
| pubmed-article:3761755 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3761755 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3761755 | pubmed:pagination | 403-8 | lld:pubmed |
| pubmed-article:3761755 | pubmed:dateRevised | 2003-11-14 | lld:pubmed |
| pubmed-article:3761755 | pubmed:meshHeading | pubmed-meshheading:3761755-... | lld:pubmed |
| pubmed-article:3761755 | pubmed:meshHeading | pubmed-meshheading:3761755-... | lld:pubmed |
| pubmed-article:3761755 | pubmed:meshHeading | pubmed-meshheading:3761755-... | lld:pubmed |
| pubmed-article:3761755 | pubmed:meshHeading | pubmed-meshheading:3761755-... | lld:pubmed |
| pubmed-article:3761755 | pubmed:meshHeading | pubmed-meshheading:3761755-... | lld:pubmed |
| pubmed-article:3761755 | pubmed:meshHeading | pubmed-meshheading:3761755-... | lld:pubmed |
| pubmed-article:3761755 | pubmed:meshHeading | pubmed-meshheading:3761755-... | lld:pubmed |
| pubmed-article:3761755 | pubmed:meshHeading | pubmed-meshheading:3761755-... | lld:pubmed |
| pubmed-article:3761755 | pubmed:meshHeading | pubmed-meshheading:3761755-... | lld:pubmed |
| pubmed-article:3761755 | pubmed:meshHeading | pubmed-meshheading:3761755-... | lld:pubmed |
| pubmed-article:3761755 | pubmed:meshHeading | pubmed-meshheading:3761755-... | lld:pubmed |
| pubmed-article:3761755 | pubmed:meshHeading | pubmed-meshheading:3761755-... | lld:pubmed |
| pubmed-article:3761755 | pubmed:meshHeading | pubmed-meshheading:3761755-... | lld:pubmed |
| pubmed-article:3761755 | pubmed:year | 1986 | lld:pubmed |
| pubmed-article:3761755 | pubmed:articleTitle | Effects of GABA-mimetic drugs on turnover of histamine in the mouse brain. | lld:pubmed |
| pubmed-article:3761755 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3761755 | lld:pubmed |
